Is It Still Worth Buying GSK After a 46% Rally in Shares This Year
GSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
This introduction explains the 5-year rule for Roth IRAs and how it affects qualified withdrawals and tax treatment.
21,792 articlesGSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
Homes.com is elevating its challenge to Zillow in the online listing arena, raising the stakes for affordability. The...
Mega-cap tech names are offering ballast as markets wobble, but the rally is fragile and depends on earnings momentum...
Two New York teens, ages 18 and 19, were arrested after an alleged explosives incident at a counter-protest near the ...
Could a $10,000 stake in Nuscale Power really turn into a fortune? This deep dive weighs the math, the regulatory hur...
IonQ posted full-year revenue of $130 million and a 2026 guidance of $225-245 million, as it leans on defense contrac...
A top executive recently disclosed selling a sizable block of Qualys stock. This article explains how to interpret in...
Oil climbs to the upper $90s per barrel as defense spending expands and aviation MRO demand stays tight. Analysts say...
Ethereum faces a potential slide toward $1,500 by the end of the third quarter if bearish momentum persists. CryptoQu...
Two substantial share sales by Klaviyo's co-CEO in February and March sparked questions about whether this is a warni...
UBS analysts view Target's planned $2 billion investment for 2026 as a bold, two-pronged turnaround bet. The plan spl...
Egg prices have fallen sharply as the worst of the avian flu outbreak eases, but traders warn that fresh outbreaks co...